Investment in response to endemic situation to strengthen strategic partnership
토토 사이트 추천 디시 bioscience, led by CEO Jaeyong Ahn, has announced the equity investment of approximately million (110 billion won) in Novavax. This move follows their recent agreement to enhance collaboration amidst the endemic landscape and to reinforce their strategic alliance.
The investment entails the acquisition of roughly 6.5 million shares of 토토 사이트 추천 디시's stock. This initiative marks a pivotal step in the two companies' evolving relationship, evolving from their previous CMO·CDMO contract established during the pandemic.
Moreover, the collaborative efforts between 토토 사이트 추천 디시 bioscience and Novavax have been extended. Notably, this expansion includes Novavax's forthcoming COVID-19 vaccine iteration designed for annual immunization, tailored to address the ongoing endemic circumstances.
토토 사이트 추천 디시 bioscience is actively finalizing the formulation of Novavax's novel COVID-19 variant vaccine at their facility known as the 'L Andong House.' The formulation incorporates the Drug Substance (DS) along with the Matrix M adjuvant. Exclusive commercial production and distribution within the South Korean market are anticipated, while non-exclusive production rights are secured for Thailand and Vietnam.
Through this strategic partnership, 토토 사이트 추천 디시 Bioscience is resolute in playing a proactive role in preventing viral infections, particularly in the endemic era. This entails a two-pronged strategy: the development of proprietary vaccines and the supply of globally developed vaccines. This comprehensive approach underscores the company's commitment to navigating the dynamic epidemiological landscape and achieving sustainable growth. Additionally, the collaborative rapport with Novavax positions 토토 사이트 추천 디시 bioscience to effectively tap into international markets, further solidifying its global standing.
John C. Jacobs, President and CEO of Novavax, commended the collaborative investment and partnership with 토토 사이트 추천 디시 bioscience. He emphasized the cooperation between the two entities as a testament to their mutual technological prowess and growth prospects. Jacobs remarked, "Our focus is on advancing commercialization and identifying future strategic opportunities, as we jointly pursue our mission of delivering life-saving vaccines across the region."
CEO of 토토 사이트 추천 디시 bioscience, Jaeyong Ahn, echoed the sentiment of a fruitful partnership. Both companies possess successful COVID-19 vaccines, cultivated during the global pandemic, enhancing the potential for synergy. Ahn emphasized that this partnership is poised to become a successful global cooperation model, bolstering growth, promoting global health, and ensuring readiness for future pandemics in a multitude of impactful ways.
